Overview

Qianlie Shule Soft Capsules are a Chinese patent medicine marketed by Tonghua Limin Pharmaceutical for the symptomatic management of benign prostatic hyperplasia (BPH) and chronic prostatitis. The product is labeled at 0.6 grams per soft capsule and supplied in packs of 45 capsules. In TCM theory, the formula is mapped to a damp-heat and qi-stagnation pattern affecting the lower jiao.

In practice, the formula is one of several TCM options considered for lower-urinary-tract symptoms (LUTS) and chronic prostatitis-like discomfort. The specific patient profile that the formula is intended for is narrower than the broad BPH label, and clinicians match the formula to a defined symptom pattern rather than to a diagnosis alone.

Indications and Pattern Logic

In Western diagnostic labeling, the formula is positioned for the symptomatic management of BPH and chronic prostatitis. In TCM pattern terms, the classical rationale focuses on the damp-heat accumulation and qi stagnation in the lower jiao, with secondary kidney yang involvement. This maps to presentations that include frequent, urgent, or painful urination, perineal discomfort, and the constitutional fatigue and pale complexion noted in the product labeling.

The pattern logic matters because it differentiates Qianlie Shule from other TCM prostate products. Formulas targeted at damp-heat emphasize clearing heat and draining dampness; formulas targeted at yang deficiency emphasize warming the kidney and restoring yang. Qianlie Shule's labeling positions it in the combined category, so it is generally considered for patients who show features of both pattern types rather than for either extreme.

Patient Population Considerations

Three patient populations commonly consider Qianlie Shule: men with mild-to-moderate BPH who have LUTS but are not yet candidates for surgical intervention; men with chronic prostatitis-like discomfort whose presentations include the constitutional features listed in the product labeling; and men in the post-acute phase of prostatitis symptoms where the residual dampness and stagnation have not yet cleared.

Clinicians typically evaluate tongue and pulse findings alongside Western diagnostics (urinalysis, ultrasound, prostate-specific antigen screening where indicated) before deciding on a TCM combination. Patients on anticoagulants or with severe hepatic or renal impairment warrant caution, and the manufacturer's package insert is the controlling reference for contraindications and adverse-event reporting.

FAQ

Q: What symptoms typically lead a clinician to consider Qianlie Shule?

A: The formula is typically considered when patients present with frequent, urgent, or painful urination, perineal discomfort, fatigue, and a pale complexion, in the setting of BPH or chronic prostatitis-like discomfort.

Q: How is the formula packaged?

A: Qianlie Shule Soft Capsules are typically supplied as 0.6-gram soft capsules in packs of 45, with labeled dosing and duration in the manufacturer package insert.

Q: Is Qianlie Shule suitable for all stages of BPH?

A: The formula is generally positioned for mild-to-moderate BPH with lower-urinary-tract symptoms. Patients with severe obstruction, acute urinary retention, or those being prepared for surgery are typically directed to Western medical management rather than TCM.

Q: Should patients on anticoagulants use this formula?

A: Patients on anticoagulant therapy or with significant hepatic or renal impairment warrant caution. The manufacturer's package insert is the controlling reference for contraindications, and patients should consult their clinician before starting any new TCM combination.